Papillomavirus Infections: all 505 studies

Page 3 of 6. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedNCT00205374Phase 4Results posted
• Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)CompletedNCT00157950Phase 3Results posted
• A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)CompletedNCT00092547Phase 3Results posted
• A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)CompletedNCT00090220Phase 3Results posted
• Long-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004Active, not recruitingNCT07820241
• Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-upCompletedNCT07807202Not applicable
• Effect of Oral Papilozumib on Vaginal and Intestinal Microbiota in Human Papillomavirus (HPV)-Positive WomenCompletedNCT07755566Not applicable
• Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)Active, not recruitingNCT07735039Not applicable
• THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNGCompletedNCT07614009Not applicable
• Gamified Learning Methods and HPV Knowledge in Nursing StudentsCompletedNCT07557719Not applicable
• Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in WomenCompletedNCT07521163Not applicable
• Parent Education About Human Papillomavirus (HPV)CompletedNCT07447245Not applicable
• Effect of Different HPV Education Methods on Vaccination Intention in Young WomenCompletedNCT07420556Not applicable
• The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination UptakeCompletedNCT07320157Not applicable
• Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 YearsActive, not recruitingNCT07281677Phase 4
• Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and CytologyCompletedNCT07244315
• PREVENT HPV -Related Cancers TrialActive, not recruitingNCT07217145Phase 3
• Cervical Pre-cancer Treatment Failure Among Women Living With HIV in ZimbabweActive, not recruitingNCT07202936
• Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)CompletedNCT07200414Not applicable
• A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) VaccineCompletedNCT07081334Phase 1
• Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPVActive, not recruitingNCT06959563Early Phase 1
• Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)CompletedNCT06919627
• Long Term Follow-up of HPV Vaccine in HIV (CTN 236)CompletedNCT06915779
• Intervention for Human Papillomavirus Vaccine Acceptance in Mexican MothersCompletedNCT06854354Not applicable
• Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal MicrobiotaCompletedNCT06802809Not applicable
• The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult WomenCompletedNCT06800456
• Communication Strategies to Increase HPV VaccinationsActive, not recruitingNCT06784960Not applicable
• Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in WomenActive, not recruitingNCT06776055
• Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV InfectionCompletedNCT06752083
• PREVENT Pilot HPV - Related Cancers TrialCompletedNCT06738355Not applicable
• Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological AssessmentCompletedNCT06700941
• The Effect of Natural Molecules on HPV InfectionCompletedNCT06661083Not applicable
• Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule BridgingActive, not recruitingNCT06632912Phase 3
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)Active, not recruitingNCT06611553Not applicable
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)Active, not recruitingNCT06611540Not applicable
• Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women SupplementActive, not recruitingNCT06577220Not applicable
• What is the Optimal Training Model for Cervical Awareness?CompletedNCT06562595Not applicable
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)Active, not recruitingNCT06498661Not applicable
• Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal InsertsCompletedNCT06491446Phase 1/2
• A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 YearsActive, not recruitingNCT06454175Phase 1
• Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)Active, not recruitingNCT06452004Not applicable
• ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV InfectionCompletedNCT06439433Phase 2
• Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).CompletedNCT06399341
• Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx CancerWithdrawnNCT06362421
• Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory DiseasesCompletedNCT06302725Not applicable
• Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 YearsActive, not recruitingNCT06281119Phase 3
• Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary CareActive, not recruitingNCT06256718Not applicable
• Effectiveness of HPV Vaccine Among Adolescents and Reproductive WomenCompletedNCT06220747
• Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV DetectionSuspendedNCT06213051
• A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) VaccineActive, not recruitingNCT06207175Phase 3
• Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive PatientsCompletedNCT06199128
• Clinic or Self-Sampling for Cervical Cancer ScreeningCompletedNCT06177236Not applicable
• Game-Based Intervention to Promote HPV VaccinationCompletedNCT06162676Not applicable
• Interferon Alpha Therapy for Cervical CINI and HPV InfectionCompletedNCT06137950Phase 1
• Understanding Women's Values in Managing Human Papillomavirus (HPV)CompletedNCT06123533
• SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer ScreeningActive, not recruitingNCT06120205Not applicable
• Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)CompletedNCT06111911Not applicable
• People Living With HIV, Oral and Oropharyngeal Cancer, and Health EquityActive, not recruitingNCT06055868
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 YearsActive, not recruitingNCT06041061Phase 3
• Serum Galectin-3 as a Marker of Human Papillomavirus InfectionCompletedNCT06005389
• The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and BeliefCompletedNCT05990270Not applicable
• HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender PopulationCompletedNCT05981807
• ORCHID: An Online Intervention for Persons With HIV (Miami)SuspendedNCT05935644Not applicable
• Research in Ethno-Medicine and Education (REMED)CompletedNCT05907187Not applicable
• HPV Self-testing in Transgender IndividualsActive, not recruitingNCT05883111Not applicable
• "Lactobacillus Crispatus M247, LSIL and Microbiota"Status unknownNCT05808816Phase 4
• Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 2
• A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineCompletedNCT05694728Phase 2
• A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineCompletedNCT05680454Phase 1
• Clinical Correlation Between Self-collected and Physician-collected HPV Screening KitsCompletedNCT05679141
• HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)SuspendedNCT05677360Not applicable
• Phase I Clinical Trial of a Candidate HPV VaccineStatus unknownNCT05672966Phase 1
• Development of a Self-collection Device for Cervical Cancer ScreeningActive, not recruitingNCT05669911Not applicable
• A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV VaccineStatus unknownNCT05668572Phase 3
• A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in ChinaActive, not recruitingNCT05662020Phase 3
• Primary Cervical Cancer Screening by Self-sampling HPV TestActive, not recruitingNCT05613283
• Human Papillomavirus in Young People Epidemiological Research 4Status unknownNCT05587738
• Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9Status unknownNCT05580341Phase 3
• Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSILActive, not recruitingNCT05555862Phase 2
• The SPOT-HPV StudyCompletedNCT05524025
• DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk InfectionsCompletedNCT05509413Not applicable
• Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual TraumaCompletedNCT05458869
• V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)Active, not recruitingNCT05450705Phase 3
• Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive AdolescentsCompletedNCT05435209Phase 4
• Immunogenicity and Safety of Co-immunization With Cecolin and HecolinStatus unknownNCT05415345Phase 4
• Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65Status unknownNCT05414929Not applicable
• Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesCompletedNCT05372016Phase 3
• Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS)WithdrawnNCT05341284
• Reducing Abundance of Human Papilloma Virus in Women by Taking ProbioticWithdrawnNCT05316064Phase 2/3
• Cervical Cancer Screening StrategiesStatus unknownNCT05309122
• Immunogenicity of Fractional Dose of the HPV VaccinesActive, not recruitingNCT05291871Phase 4
• Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)Active, not recruitingNCT05285826Phase 3
• The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella VaccineStatus unknownNCT05279248Phase 4
• Prevention and Screening Towards Elimination of Cervical CancerCompletedNCT05234112Not applicable
• Clinical Evaluation of Detection of High Risk HPV in UrineStatus unknownNCT05210348
• Health Belief Model Based Education on Human Papilloma Virus Infection and VaccinationCompletedNCT05175482Not applicable
• Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital WartsCompletedNCT05156541Phase 3
• Probiotics Role in HPV Cervico-vaginal Infection ClearanceCompletedNCT05109533Not applicable
• HPV and Male Homosexuality in General Practice?CompletedNCT05078554
• Human Papilloma Virus (HPV) Self-collection and Women AdherenceStatus unknownNCT05059015Not applicable

← Papillomavirus Infections overview